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year available), there were 1281 large incidents (≥500 affected
individuals) and 164 127 small incidents (<500 affected
individuals).2-4 In aggregate, the large incidents affected ap-
proximately52million individualswhile thesmall incidentsaf-
fected0.8millionindividuals.Thesestatisticssuggest that, from
a public policy perspective, large incidents have the potential
to significantly impact more individuals than small incidents.
Thus, larger breach incidents might deserve special attention
from the government, industry, and research community. We
do agree that all hospitals should take action tomitigate risk of
databreachesandthatsmallerbreachesalsodeservemoretrans-
parency because breached patient information does have hu-
manconsequences, irrespectiveof thebreachsizewhere the in-
formation was compromised.
Drs Fabbri et al suggested that our results are affected by
theHHSdata collection process because only a PHI breach af-
fecting 500ormore individuals requiresHHSnotification.We
disagree. The HITECHA requires heath plan, health care pro-
viders, and business associates (ie, covered entities) to report
all PHI breaches to HHS. There is no evidence, to our knowl-
edge, that HHS has not been enforcing the law.
DrsFabbri et al argued thathospitals that areunable tode-
tect or did not actually detect data breach incidents are ex-
cluded from HHS public reporting. This is possible and con-
sistentwith the perception that the health care sector has not
beenan industry leader in information security.5However,we
believe that the number of these hospitals is likely to be lim-
ited because the vigilance of the public may compensate for
these hospitals’ lack of detection ability. Patients whose in-
formation is compromisedusually complain to thehospital or
HHS, facilitating the detecting and subsequent reporting of
breaches. From2003 to 2014, theHHS received 108031 com-
plaints alleging covered entities disclosing patients’ PHI
inappropriately.6
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Considerations for County-Level Inequalities
in Life Expectancy
TotheEditor InanOriginal Investigationpublished inarecent is-
sueofJAMAInternalMedicine,Dwyer-Lindgrenandcolleagues1
showed the existence andgrowthof alarmingly large inequali-
ties in life expectancy across counties in the United States—up
toadisturbing20-year gapbetween thehighest and lowest life
expectancies between counties. I agree with the authors that
thesefindingsdemandactionbecause inequalitieswill continue
to growunabatedly in the face of inaction.
Dwyer-Lindgren and colleagues1 examined as mediators
several demographic, socioeconomic, behavioral and meta-
bolic, and health care factors, finding that they accounted for
almost 75%of thevariation in life expectancy. Importantly, the
authors acknowledged the lack of other likely factors driving
the inequalities observed. I believe diet quality, alcohol and
drug abuse, and housing conditions are some of the critical
missing factors in the analysis.2 In their Figure1 showing life
expectancybycounty,BaltimoreCity standsout inorange (life
expectancy ≤75 years) among its green and blue neighboring
counties (life expectancy ≥80 years). County-level data from
the County Health Rankings project3 show that the propor-
tionof theBaltimoreCitypopulation that experiences food in-
security is 24%, twice and thrice that observed in neighbor-
ing counties; 24% is also the proportion of households that
experience dire housing problems like very high cost burden,
severe overcrowding, and lack of kitchen or plumbing facili-
ties—again much higher than in neighboring counties. Fi-
nally,witha residential segregation indexof69,BaltimoreCity
remains themost racially segregated county inMaryland.3Fu-
ture researchmust consider thesecritical behavioral andstruc-
tural factors—particularlydiet andhousing conditions—asme-
diators of inequalities in life expectancy across counties.
Dwyer-Lindgrenandcolleagues1 also found that socioeco-
nomic factors no longer explained the variation in life expec-
tancy when all other factors were considered; thus, the au-
thors suggested that the association between life expectancy
and socioeconomic factors is largely mediated by behavioral
andmetabolic risk factors. Iwould like to cautionagainst such
conclusions, as evidence from largemulticohort analyses4 in-
dicates that the observed socioeconomic variation in all-
cause and cause-specific mortality—key factors in life expec-
tancy—remains large and significant after behavioral and
metabolic factors are accounted for. Doing so risks encourag-
ing public health efforts and resources to focus on the indi-
vidual,mistakenly ignoring the crucial roleof structural forces
that drive population and individual behavior, thereby ham-
pering efforts to reduce inequalities in life expectancy.
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InReplyOurstudy1on inequalities in lifeexpectancy foundthat
acombinationof socioeconomicandrace/ethnicity factors, be-
havioral and metabolic risk factors, and health care factors
could explain 74% of the variation in life expectancy among
counties. We agree with Dr Mestral that other factors such as
diet quality andhousing conditionsmayplay a role in explain-
ing the remaining variation. This is an important area of fu-
ture research andwill require identifying appropriate county-
level data sources that relate to these factors.
Our study1 also found thatmuchof the effect at the county
levelofvariation insocioeconomicfactorsonvariation in lifeex-
pectancywasmediatedvia risk factors.Wedonot interpret this
tomeanthat risk factorsshouldbethesole focusofefforts to im-
provepopulationhealth. Socioeconomic factorsare important,
notonly forhealth,but forwell-beingandprosperitymoregen-
erally. Our research1 suggests that both socioeconomic and ra-
cial inequalities,aswellasbehavioralandmetabolic risk factors,
areimportanttargetsfor improvingpopulationhealthandreduc-
ing inequalities. After all, individuals with low socioeconomic
status areoften themost impactedby these risk factors andare
themost likely to benefit from such a strategy.
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Perplexing Conclusions ConcerningHeat-Not-Burn
Tobacco Cigarettes
To the Editor While we welcome independent studies on our
products, in a Research Letter published in a recent issue of
JAMAInternalMedicineAueret al1 describedachemical analy-
sis of the IQOS aerosol that we find perplexing in several re-
spects.Accuracy in science is, of course, always important.We
believe that it is especially important in relation to poten-
tially lessharmful alternatives tocigarettes toensure thatadult
smokers receive accurate information.
While someof the results reportedbyAuer et al1 seemcon-
sistent with those that we have previously published, signifi-
cant points of difference in the described methodologies may
account for the disagreements compared with our peer-
reviewed and published data.2 For example, the reported ac-
rolein yield for the tested cigarette is 50 times below the level
reported for similar cigarettesbyHealthCanada.3 It seems that
Auer et al1 neither validated theirmethodswith a standard ref-
erence cigarette nor compared their results with those pub-
lished by a recognized regulatory agency. Further apparent
methodological shortcomings are described in our full review
of the article.4 Because we understand the importance of sci-
entific rigorand thepotential for skepticismaroundtobacco in-
dustry–generated data, we also commissioned an indepen-
dentandaccredited laboratory toanalyze the IQOSaerosol.The
relevant data were published on http://www.pmiscience.com
andsubmittedaspartofourModifiedRiskTobaccoProductap-
plication to the US Food and Drug Administration.5
We have scientifically demonstrated the absence of com-
bustion in IQOS.5,6 Thishasbeencorroboratedby several com-
bustion experts.
In theirResearchLetter,Aueretal1didnotpresentanydata
regarding the impact of IQOSuse on indoor air quality. In con-
trast, we produced and published data using validatedmeth-
ods that show that the use of IQOS does not negatively im-
pact indoor air quality according to international standards.6
Werecognize theneedtoscrutinize thescientificworkper-
formedby the tobacco industry. Itwould seemequally impor-
tant to scrutinize thework emanating from academia.We are
therefore puzzled that the peer review system did not iden-
tify some of the methodological and interpretational find-
ings outlined in our review.4
Philip Morris International transparently communicates
its study results,6 including that IQOS yields over 90% lower
levels of toxicants than the reference cigarette 3R4Fand isnot
risk free.4-6Thetotalityof theevidencecollected todate, across
a broad range of toxicology, systems toxicology, and clinical
studies, indicates that IQOS has the potential to present less
riskofharmcomparedwithcontinuedsmoking foradult smok-
ers who switch to it completely.6
Serge Maeder, PhD
Manuel C. Peitsch, PhD
Author Affiliations: Philip Morris International Testing Laboratories &
Analytical Research, Switzerland (Maeder); Philip Morris International, Quai
Jeanrenaud 5, 2000Neuchâtel, Switzerland (Peitsch).
Corresponding Author:Manuel C. Peitsch, PhD, Philip Morris International,
Quai Jeanrenaud 5, 2000Neuchâtel, Switzerland (manuel.peitsch@pmi.com).
Conflict of Interest Disclosures: The authors are fully paid employees of Philip
Morris International (PMI), the manufacturer of IQOS. All studies conducted by
PMI with IQOSwere solely funded by PMI.
1. Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A.
Heat-not-burn tobacco cigarettes: smoke by any other name. JAMA Intern Med.
2017;177(7):1050-1052. doi:10.1001/jamainternmed.2017.1419
Letters
1698 JAMA Internal Medicine November 2017 Volume 177, Number 11 (Reprinted) jamainternalmedicine.com
© 2017 American Medical Association. All rights reserved.
Downloaded from jamanetwork.com by UNIVERSITE DE LAUSANNE user on 01/24/2019
